Compare Edwards Lifesciences Corporation Common Stock (EW) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Visa Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Visa Inc trades at $375 (market cap $698.56B). The key difference: Visa Inc is far larger — about 14.1× Edwards Lifesciences Corporation Common Stock's market cap, and Visa Inc pays a 0.72% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | V | |
|---|---|---|
Market Cap | $49.44B | $698.56B |
Volume | 3,508,027 | 4,446,146 |
Sector | Health | Financials |
52-Week High | $95.18 | $384.14 |
52-Week Low | $72.65 | $295.52 |
Enterprise Value | $45.90B | $709.14B |
Typical Hold Time | — | 115 Days |
Dividend Yield | — | 0.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Visa (V) trades at $375.10, up 1.2% today, with a bullish technical outlook and strong fundamentals. The stock shows robust revenue growth, with 2025 revenue reaching $40 billion and net income of $20.06 billion, supported by high profitability margins. Recent earnings beats and a consensus analyst price target of $422.24 reflect positive sentiment, while news highlights AI integration and stablecoin partnerships as growth catalysts.
The outlook for Visa remains favorable, driven by earnings momentum and strategic initiatives in digital payments. Key risks include competitive pressures from fintech and regulatory scrutiny, but institutional ownership trends and a dominant market position underpin long-term potential. The stock offers upside based on analyst targets, though investors should monitor execution on AI and payment innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
